Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 61 for “"JQ1"”.

  1. Der antiproliferative Effekt des epigenetischen BRD4- Inhibitors JQ1 auf den proliferativen Phänotyp humaner kolorektaler Karzinomzellen

    Der niedermolekulare Inhibitor JQ1 bindet an der Bromodomäne von BRD4, ein auf epigenetischer Ebene agierendes Protein. Der antiproliferative Effekt von JQ1 wurde bisher bei verschiedenen Tumorentitäten vor allem des lymphatischen und blutbildenden Systems gezeigt. In dieser Arbeit wurde der …

    wurz-thes Repository record for Der antiproliferative Effekt des epigenetischen BRD4- Inhibitors JQ1 auf den proliferativen Phänotyp humaner kolorektaler Karzinomzellen (opens in a new tab)

  2. Evaluation of the combination treatment docetaxel and JQ1 in 2D and 3D preclinical models of prostate cancer

    … therapeutic strategies should be explored. JQ1, a potent and selective Bromodomain and extra terminal domain (BET) inhibitor, is a potentially potent therapy for patients with mCRPC. Compared to new hormonal agents, JQ1 more potently abrogates BRD4 localization to the AR target loci and …

    fu-berlin Repository record for Evaluation of the combination treatment docetaxel and JQ1 in 2D and 3D preclinical models of prostate cancer (opens in a new tab)

  3. Inhibition of BET bromodomain proteins reverses glucolipotoxicity and improves insulin secretion from clonal pancreatic beta-cells (INS-1)

    … progressive pancreatic beta-cell dysfunction. JQ1, a pan-bromodomain and extra-terminal (BET) protein inhibitor, has previously been shown to increase fatty acid oxidation and insulin content in pancreatic beta cells, but its ability to counteract glucolipotoxicity specifically has not been …

    bu Repository record for Inhibition of BET bromodomain proteins reverses glucolipotoxicity and improves insulin secretion from clonal pancreatic beta-cells (INS-1) (opens in a new tab)

  4. Developing Novel and Effective Treatments for Pancreatic Ductal Adenocarcinoma

    … treat PDAC. We have shown that the BET inhibitor JQ1 suppressed PDAC tumor growth in patient-derived xenograft (PDX) mouse models. This dissertation details the use of in vitro and in vivo models of PDAC to elucidate the mechanism by which JQ1 inhibited tumor growth as a single agent and the use …

    uab Repository record for Developing Novel and Effective Treatments for Pancreatic Ductal Adenocarcinoma (opens in a new tab)

  5. TARGETING THE EPIGENETIC MECHANISM IN ACUTE MYELOID LEUKAEMIA

    … IN TREATMENT OF AML. ANEW SMALL MOLECULAR DRUG, JQ1, TARGETING THE EPIGENETIC READER BRD4, HAS BEEN SHOWN TO INDUCE CELL CYCLE ARREST IN DIFFERENT CANCERS THROUGH INHIBITING THE WELL-KNOWN ONCOGENE, MYC. HOWEVER, OTHER MECHANISMS OF JQ1 HAVE NOT BEEN WELL STUDIED IN AML. IN THIS STUDY, I FOUND …

    nus Repository record for TARGETING THE EPIGENETIC MECHANISM IN ACUTE MYELOID LEUKAEMIA (opens in a new tab) Download file for TARGETING THE EPIGENETIC MECHANISM IN ACUTE MYELOID LEUKAEMIA (opens in a new tab)

  6. Disrupção da sinalização epigenética da histona através da inibição farmacológica do BRD4 na biologia dos carcinomas de cabeça e pescoço

    … (CECP). Para esse propósito, foi utilizado JQ1, inibidor de BRD4, em concentração de 1uM, nas linhagens de carcinoma de cabeça e pescoço HN6, HN12 e HN13. Foi analisado os níveis de BRD4, H4 acetilada e SIRT1 fosforilado através de reações de imunofluorecência e p16ink4 por …

    brazil-ufrgs Repository record for Disrupção da sinalização epigenética da histona através da inibição farmacológica do BRD4 na biologia dos carcinomas de cabeça e pescoço (opens in a new tab)

  7. Resistance to BET inhibitors in lung adenocarcinoma is mediated through casein kinase 2 phosphorylation of BRD4

    … that have complex underlying mechanisms. JQ1 is a small-molecule inhibitor of the bromodomain and extraterminal (BET) family proteins, which function as important reader molecules of acetylated histones and recruit transcriptional activators to specific promoter sites. In many cancer lines …

    ubc Repository record for Resistance to BET inhibitors in lung adenocarcinoma is mediated through casein kinase 2 phosphorylation of BRD4 (opens in a new tab) Download PDF for Resistance to BET inhibitors in lung adenocarcinoma is mediated through casein kinase 2 phosphorylation of BRD4 (opens in a new tab)

  8. Ansprechen auf und Resistenz gegen BET-Inhibitoren bei triple-negativem Brustkrebs

    … (MDA-MB-231R) resistant to the BET inhibitor JQ1 was established from the parental cell line MDA-MB-231. The cytotoxicity of the medications following treatments was assessed using the MTT test. The cell cycle, cell apoptosis, and BH3 profiling analyses were carried out using FACS analysis. …

    fu-berlin Repository record for Ansprechen auf und Resistenz gegen BET-Inhibitoren bei triple-negativem Brustkrebs (opens in a new tab)

  9. Characterising Drug Resistance in the Colorectal Cancer Cell Line RKO

    … Irinotecan, Oxaliplatin, Miyabeacin, I-BET, JQ1, Rucaparib and Olaparib in a cell viability assay, also using MTT. Verapamil was added in combination with the last five of the compounds mentioned. The doubling time of RKO was 14.5 ± 0.4 hrs, RKOr5-FU was 18.0 ± 1.6 hrs, RKOrIRINO was 24.0 ± …

    kent Download PDF for Characterising Drug Resistance in the Colorectal Cancer Cell Line RKO (opens in a new tab)

  10. BET Bromodomain Inhibition as an Approach for Treatment of Cholangiocarcinoma

    … We previously reported that the BET inhibitor JQ1 lead to significant growth reduction and decreased c- Myc expression in a patient-derived xenograft (PDX) model of CCA. Further, downregulation of c-Myc transcriptional target, Chk1, was also observed. This dissertation details the use of in …

    uab Repository record for BET Bromodomain Inhibition as an Approach for Treatment of Cholangiocarcinoma (opens in a new tab)

  11. Identification of chromatin modifying mechanisms in inflammatory macrophages in rheumatoid arthritis

    … and extra-terminal (BET) protein inhibitors (JQ1, I-BET151, PFI-1) were the only class of inhibitor to show consistent down regulation of pro-inflammatory cytokines in both healthy and RA patient-derived macrophages. However, only JQ1 was shown to reduce TNFα production significantly in SF …

    oxford Repository record for Identification of chromatin modifying mechanisms in inflammatory macrophages in rheumatoid arthritis (opens in a new tab)

  12. Structural Determinants for Histone and Inhibitor Recognition by the Bromodomain Protein 4

    … histone tails and to the BET inhibitor JQ1 were analyzed using several complementary biochemical and biophysical methods. Altogether, the results show that W81, Y97, N140 and M149 play similarly important roles in the recognition of acetylated histones and JQ1. P82, L94, D145 and I146 …

    fu-berlin Repository record for Structural Determinants for Histone and Inhibitor Recognition by the Bromodomain Protein 4 (opens in a new tab)

  13. Multiple Roles of Brd4 in the Human Papillomavirus Life Cycle

    … mitosis while the BET bromodomain inhibitor, JQ1(+), dissociates Brd4–E2 complexes from mitotic chromosomes. These results suggest that Brd4 is important for tethering HPV16 E2 to mitotic chromosomes for stable viral genome maintenance and that abrogating Brd4's chromatin association might …

    penn Repository record for Multiple Roles of Brd4 in the Human Papillomavirus Life Cycle (opens in a new tab)

  14. Epigenetic regulators contributing to MYCN-driven neuroblastoma

    … outcome, and the BET bromodomain inhibitors JQ1 and I-BET151 reduced N-Myc expression and reactivated TP53INP1 expression in neuroblastoma cells. The BET bromodomain proteins BRD3 and BRD4 have recently been shown to play critical roles in MYC gene transcription, and the BRD3/BRD4 inhibitors …

    unsw Repository record for Epigenetic regulators contributing to MYCN-driven neuroblastoma (opens in a new tab)

  15. Molecular characterisation of paediatric ALL and new therapeutic strategies

    … that treatment with the BET protein inhibitor JQ1 led to potent in vitro sensitisation of ALL tumour cells regardless of cellular phenotype, as well as in vivo sensitisation using xenograft models of ALL. I observed strong in vitro synergy in ALL cell lines and primary tumours treated with a …

    birmingham Download PDF for Molecular characterisation of paediatric ALL and new therapeutic strategies (opens in a new tab)

  16. CHARACTERIZATION OF THE BIOLOGICAL AND CLINICAL RELEVANCE OF RUNX GENES IN NATURAL KILLER/T-CELL LYMPHOMA

    … TREATMENT WITH A SMALL-MOLECULE MYC INHIBITOR (JQ1) CAUSED SIGNIFICANT DOWNREGULATION OF MYC AND RUNX3 IN A DOSE-DEPENDENT MANNER, LEADING TO APOPTOSIS IN NKTCL CELL LINES. OUR STUDY IDENTIFIED RUNX3 OVEREXPRESSION IN NKTCL WITH FUNCTIONAL ONCOGENIC PROPERTIES. WE FURTHER DELINEATE THAT MYC MAY …

    nus Repository record for CHARACTERIZATION OF THE BIOLOGICAL AND CLINICAL RELEVANCE OF RUNX GENES IN NATURAL KILLER/T-CELL LYMPHOMA (opens in a new tab) Download file for CHARACTERIZATION OF THE BIOLOGICAL AND CLINICAL RELEVANCE OF RUNX GENES IN NATURAL KILLER/T-CELL LYMPHOMA (opens in a new tab)

  17. Deregulation Of The Hippo Pathway Suppresses Differentiation And Promotes Sarcomagenesis

    … of HDAC (Vorinostat) and BET bromodomain (JQ1) inhibition partially restores differentiation to skeletal muscle UPS cells and tissues, enforcing a myoblast-like identity. Importantly, differentiation is contingent upon downregulation of the Hippo pathway transcriptional effector, …

    penn Repository record for Deregulation Of The Hippo Pathway Suppresses Differentiation And Promotes Sarcomagenesis (opens in a new tab)

  18. Relevance of HIV infection to osteoblast-T cell crosstalk

    … antagonist, as well as the novel compound JQ1, an inflammatory inhibitor that targets bromodomain-containing proteins. Both rapamycin and JQ1 efficiently blocked the cytotoxic effects of supernatants from non-infected activated T cells on osteoblasts, whereas only rapamycin prevented …

    bu Repository record for Relevance of HIV infection to osteoblast-T cell crosstalk (opens in a new tab)

  19. MECHANISTIC INVESTIGATION OF BRD4 INHIBITION IN MYC DEPENDENT TUMORS

    … profiles in Burkitt’s Lymphomas in response to JQ1. Our results demonstrate that BETs inhibitors efficacy is dependent on global alteration of RNA PolII dynamics, due to the role of BRD4 in regulating elongation. Yet, despite a pervasive eviction of BRD4 from chromatin and the global effect on …

    milano Repository record for MECHANISTIC INVESTIGATION OF BRD4 INHIBITION IN MYC DEPENDENT TUMORS (opens in a new tab)

  20. Divergent Transcriptional Regulation of Suppressors of Cytokine Signaling Genes in Adipocytes

    … transcription. Treatment with the BET inhibitor JQ1 produced the same divergent effects as HDAC inhibition on both Socs3 and Cish gene expression, as well as on RNA polymerase II binding. Moreover, BET proteins help drive productive elongation of mRNA by recruiting the positive transcription …

    lsu-thes Repository record for Divergent Transcriptional Regulation of Suppressors of Cytokine Signaling Genes in Adipocytes (opens in a new tab)

Page 1 of 4